ACEi reduces hypertension-induced hyperinflammation in COVID-19

Antihypertensive therapy, particularly with the use of an angiotensin-converting enzyme inhibitor, improves outcomes in patients with hypertension and SARS-CoV-2 infection, who are susceptible to hyperinflammation and severe outcomes with COVID-19.

Detalles Bibliográficos
Autor principal: Lim, Gregory B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812557/
https://www.ncbi.nlm.nih.gov/pubmed/33462417
http://dx.doi.org/10.1038/s41569-021-00512-9
_version_ 1783637694591533056
author Lim, Gregory B.
author_facet Lim, Gregory B.
author_sort Lim, Gregory B.
collection PubMed
description Antihypertensive therapy, particularly with the use of an angiotensin-converting enzyme inhibitor, improves outcomes in patients with hypertension and SARS-CoV-2 infection, who are susceptible to hyperinflammation and severe outcomes with COVID-19.
format Online
Article
Text
id pubmed-7812557
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78125572021-01-18 ACEi reduces hypertension-induced hyperinflammation in COVID-19 Lim, Gregory B. Nat Rev Cardiol Research Highlight Antihypertensive therapy, particularly with the use of an angiotensin-converting enzyme inhibitor, improves outcomes in patients with hypertension and SARS-CoV-2 infection, who are susceptible to hyperinflammation and severe outcomes with COVID-19. Nature Publishing Group UK 2021-01-18 2021 /pmc/articles/PMC7812557/ /pubmed/33462417 http://dx.doi.org/10.1038/s41569-021-00512-9 Text en © Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research Highlight
Lim, Gregory B.
ACEi reduces hypertension-induced hyperinflammation in COVID-19
title ACEi reduces hypertension-induced hyperinflammation in COVID-19
title_full ACEi reduces hypertension-induced hyperinflammation in COVID-19
title_fullStr ACEi reduces hypertension-induced hyperinflammation in COVID-19
title_full_unstemmed ACEi reduces hypertension-induced hyperinflammation in COVID-19
title_short ACEi reduces hypertension-induced hyperinflammation in COVID-19
title_sort acei reduces hypertension-induced hyperinflammation in covid-19
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812557/
https://www.ncbi.nlm.nih.gov/pubmed/33462417
http://dx.doi.org/10.1038/s41569-021-00512-9
work_keys_str_mv AT limgregoryb aceireduceshypertensioninducedhyperinflammationincovid19

Ejemplares similares